Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides

Arwin J Brouwer, Natalia Herrero Álvarez, Adriano Ciaffoni, Helmus van de Langemheen, Rob M J Liskamp

    Research output: Contribution to journalArticleAcademicpeer-review

    Abstract

    The success of inhibition of the proteasome by formation of covalent bonds is a major victory over the long held-view that this would lead to binding the wrong targets and undoubtedly lead to toxicity. Great challenges are now found in uncovering ensembles of new moieties capable of forming long lasting ties. We have introduced peptido sulfonyl fluorides for this purpose. Tuning the reactivity of this electrophilic trap may be crucial for modulating the biological action. Here we describe incorporation of a vinyl moiety into a peptido sulfonyl fluoride backbone, which should lead to a combined attack of the proteasome active site threonine on the double bond and the sulfonyl fluoride. Although this led to strong proteasome inhibitors, in vitro studies did not unambiguously demonstrate the formation of the proposed seven-membered ring structure. Possibly, formation of a seven-membered covalent adduct with the proteosomal active site threonine can only be achieved within the context of the enzyme. Nevertheless, this dual warhead concept may provide exclusive possibilities for duration and selectivity of proteasome inhibition.

    Original languageEnglish
    Pages (from-to)3429-3435
    Number of pages7
    JournalBioorganic and Medicinal Chemistry
    Volume24
    Issue number16
    DOIs
    Publication statusPublished - 15 Aug 2016

    Keywords

    • Drug Design
    • peptido vinyl sulfonyl fluoride
    • proteasome
    • irreversible inhibition
    • dual warhead

    Fingerprint

    Dive into the research topics of 'Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides'. Together they form a unique fingerprint.

    Cite this